title: CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
authors.affiliation: Department of Medical and Surgical Oncology, Alexander Fleming Institute, Buenos Aires, Argentina.
authors.forename: Matías
authors.initials: M
authors.lastname: Chacón
authors.forename: Enrique
authors.initials: E
authors.lastname: Roca
authors.forename: Eduardo
authors.initials: E
authors.lastname: Huertas
authors.forename: Fernando Sanchez
authors.initials: FS
authors.lastname: Loria
authors.forename: Enzo
authors.initials: E
authors.lastname: Domenechini
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate